Chronic fatigue: Drug addiction medicine Naltrexone could treat condition

Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for Fibromyalgia

GuruFocus
20 June 2022
https://www.gurufocus.com/news/1770836/scilex-a-sorrento-company-highlights-safety-data-from-phase-1-trial-of-sp104-a-proprietary-low-dose-naltrexone-for-fibromyalgia

What to know about LDN for rheumatoid arthritis

Medical News Today
21 June 2022
https://www.medicalnewstoday.com/articles/ldn-for-rheumatoid-arthritis

Low dose naltrexone (LDN) is a medication. Some researchers believe LDN can help with autoimmune diseases, such as multiple sclerosis, Crohn’s disease, and psoriasis. For this reason, some scientists have looked into the potential efficacy of LDN in treating rheumatoid arthritis (RA). 

Reversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma

J Drugs Dermatol
01 June 2022
https://pubmed.ncbi.nlm.nih.gov/35674753/

LDN Webinar Presentation 18 May 2022: Dr Masoud Rashidi - LDN, Dosing, Fillers and Compounded Options. LDN, ULDN and Pain/Opioid Issues

Sponsored by Innovative Compounding Pharmacy https://icpfolsom.com/